Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Shares Outstanding 2010-2025 | EVO

Evotec AG shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  
Evotec AG Annual Shares Outstanding
(Millions of Shares)
2024 355
2023 354
2022 353
2021 333
2020 308
2019 299
2018 295
2017 290
2016 265
2015 263
2014 263
2013 242
2012 235
2011 225
2010 199
2009 0
Evotec AG Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 355
2024-12-31 355
2024-09-30 355
2024-06-30 355
2024-03-31 355
2023-09-30 354
2023-06-30 354
2022-12-31 353
2022-09-30 353
2022-06-30 353
2022-03-31 353
2021-12-31 333
2021-09-30 329
2021-06-30 329
2021-03-31 328
2020-12-31 308
2020-09-30 302
2020-06-30 302
2020-03-31 302
2019-12-31 299
2019-09-30 300
2019-06-30 299
2019-03-31 298
2018-12-31 295
2018-09-30 295
2018-06-30 295
2018-03-31 295
2017-12-31 290
2017-09-30 291
2017-06-30 293
2017-03-31 279
2016-12-31 265
2016-09-30 265
2016-06-30 265
2016-03-31 265
2015-12-31 263
2015-09-30 263
2015-06-30 263
2015-03-31 263
2014-12-31 203
2014-09-30 263
2014-06-30 263
2014-03-31 262
2013-12-31 242
2013-09-30 238
2013-06-30 236
2013-03-31 236
2012-12-31 234
2012-09-30 235
2012-06-30 245
2012-03-31 199
2011-12-31 242
2011-09-30 234
2011-06-30 243
2011-03-31 229
2010-12-31 224
2010-09-30 215
2010-06-30 215
2010-03-31 258
2009-12-31
2009-09-30 214
2009-06-30 214
2009-03-31 212
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.424B $0.862B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.152B 31.57
Zoetis (ZTS) United States $75.067B 28.01
Takeda Pharmaceutical (TAK) Japan $47.697B 9.49
Daiichi Sankyo, - (DSNKY) Japan $46.849B 23.83
Sandoz Group AG (SDZNY) Switzerland $23.527B 0.00
Merck (MKKGY) Germany $17.005B 12.46
Summit Therapeutics (SMMT) United States $14.653B 0.00
United Therapeutics (UTHR) United States $14.421B 12.76
Shionogi (SGIOY) Japan $14.275B 14.30
Neurocrine Biosciences (NBIX) United States $12.332B 42.24
Orion OYJ (ORINY) Finland $10.083B 27.27
IPSEN (IPSEY) France $10.039B 0.00
Corcept Therapeutics (CORT) United States $7.318B 59.49
Stevanato Group S.p.A (STVN) Italy $7.038B 43.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.086B 0.00
Grifols, S.A (GRFS) Spain $5.995B 0.00
Ionis Pharmaceuticals (IONS) United States $5.609B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.791B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.093B 10.84
Crinetics Pharmaceuticals (CRNX) United States $3.026B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 19.46
BioCryst Pharmaceuticals (BCRX) United States $2.298B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.247B 12.15
NewAmsterdam Pharma (NAMS) Netherlands $2.190B 0.00
Indivior (INDV) United States $1.874B 7.95
Recursion Pharmaceuticals (RXRX) United States $1.858B 0.00
Dyne Therapeutics (DYN) United States $1.590B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.584B 0.00
Ocular Therapeutix (OCUL) United States $1.348B 0.00
Guardian Pharmacy Services (GRDN) United States $1.324B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Harrow (HROW) United States $1.054B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Akebia Therapeutics (AKBA) United States $0.969B 0.00
Collegium Pharmaceutical (COLL) United States $0.948B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.913B 0.00
Ardelyx (ARDX) United States $0.871B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.697B 0.00
KalVista Pharmaceuticals (KALV) United States $0.686B 0.00
Xencor (XNCR) United States $0.649B 0.00
Liminatus Pharma (LIMN) United States $0.640B 0.00
AleAnna (ANNA) United States $0.608B 0.00
Elite Pharmaceuticals (ELTP) United States $0.595B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.555B 0.00
USANA Health Sciences (USNA) United States $0.541B 11.77
Theravance Biopharma (TBPH) United States $0.539B 0.00
Bioventus (BVS) United States $0.535B 13.56
Verve Therapeutics (VERV) United States $0.511B 0.00
Tourmaline Bio (TRML) United States $0.485B 0.00
Zevra Therapeutics (ZVRA) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.456B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.450B 0.00
Altimmune (ALT) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.420B 8.78
Savara (SVRA) United States $0.411B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 10.13
Organogenesis (ORGO) United States $0.365B 0.00
Aquestive Therapeutics (AQST) United States $0.355B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.68
MediWound (MDWD) Israel $0.234B 0.00
ProKidney (PROK) United States $0.230B 0.00
Esperion Therapeutics (ESPR) United States $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.181B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
OmniAb (OABI) United States $0.169B 0.00
Larimar Therapeutics (LRMR) United States $0.158B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Wellgistics Health (WGRX) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Unicycive Therapeutics (UNCY) United States $0.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.090B 14.77
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Lyra Therapeutics (LYRA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00